Lv4
406 积分 2021-11-22 加入
[New perspectives in the management of dyslipidemia and the role of PCSK9 inhibitors]
4天前
求助中
Lipid-lowering therapy in transition: implications of the ESC/EAS focused update
4天前
求助中
Choledocholithiasis Can Present with Marked Transaminases Elevation: Systematic Review and Meta-Analysis
4天前
已完结
Analysis of Efficacy and Safety of Laparoscopy Plus Choledochoscopy Combined With Holmium Laser Lithotripsy for Choledocholithiasis and Hepatolithiasis
4天前
已完结
Hepatolithiasis, a clinical study
4天前
求助中
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival
10天前
已完结
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
10天前
已完结
Single‐Dose Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of the Soluble Guanylate Cyclase Stimulator BAY 63‐2521: An Ascending‐Dose Study in Healthy Male Volunteers
12天前
已完结
Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the future
12天前
已完结
Pulmonary hypertension trials: how can we do better?
12天前
已关闭
皖公网安备34019202002308
